protocolSection identificationModule nctId: NCT06346028, orgStudyIdInfo id: 2023/086, briefTitle: Implementation of Transcranial Magnetic Stimulation for Smoking Cessation, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-04-03, lastUpdatePostDateStruct date: 2024-04-03, sponsorCollaboratorsModule leadSponsor name: Centre for Addiction and Mental Health, class: OTHER, descriptionModule briefSummary: Repetitive transcranial magnetic stimulation (rTMS) is an alternative non-invasive treatment to help people quit smoking. rTMS uses a magnetic field to stimulate regions of the brain that are involved in addiction. The two brain regions that are stimulated are the insula and the dorsolateral prefrontal cortex, which are involved in drug craving and decision-making, respectively.The goal of this clinical trial is to learn more about the feasibility of offering rTMS as a treatment in the Nicotine Dependence Clinic (NDC) to help daily smokers to quit smoking. The NDC is at the Center for Addiction and Mental Health (CAMH) at 1025 Queen Street West, in Toronto, Canada.Participants will be asked to come to CAMH to:* Complete surveys and optional interviews to learn more about their opinions and experiences with this treatment* Start a treatment course that includes 3 weeks of daily (Monday to Friday) rTMS sessions followed by 3 weeks of weekly rTMS sessions for a total of 6 weeks. Each session lasts about 25 minutes and is provided by an rTMS technician with medical supervision.Objectives• Learning about the feasibility of rTMS as a treatment option for patients in the NDC will help us improve the treatment when offering it in other clinics, which may help improve smoking quit rates and people's overall health., conditionsModule conditions: Smoking, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Brainsway H4 deep rTMS coil and Brainsway stimulator system, outcomesModule primaryOutcomes measure: The primary objective of the study is to evaluate the feasibility of implementing rTMS in the Nicotine Dependence Clinic (NDC) at CAMH, in Toronto. This is determine by reach, the extent to which patients are engaging in the rTMS treatment., primaryOutcomes measure: Identify rates of adoption of rTMS in Nicotine Dependence Clinic, primaryOutcomes measure: Identify contextual determinants of rTMS adoption and reach NDC through a qualitative approach., secondaryOutcomes measure: Evaluate the effectiveness of rTMS on smoking cessation rates in real world patients with common comorbidities seeking treatment at NDC., secondaryOutcomes measure: Explore patient-HCP communication about shared treatment decision-making for rTMS., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Center for Addiction and Mental Health (CAMH), status: RECRUITING, city: Toronto, state: Ontario, country: Canada, contacts name: Alexandra S, BScH, role: CONTACT, phone: 416-535-8501, phoneExt: 31551, email: rtms.smoking@camh.ca, geoPoint lat: 43.70011, lon: -79.4163, hasResults: False